- Non-invasive prenatal testing (NIPT)
- Pre-implantation genetic screening (PGS)
- Pre-implantation genetic diagnosis (PGD)
- BRCA 1 & 2 panel
- Cancer hotspot panel
- Lung Cancer mutation panel
- RAS Extended Plus for Colorectal Cancer
- Thyroid cancer mutation profile
- AML mutation panel
- GIST mutation panel
- Prostate cancer mutation panel
- ABL1 TKI resistance mutations
- MPN mutations
- TP53 mutation
- GIST mutation panel
- IDH1 & IDH2 mutations for glioma
- KIT D816V mutation
- FGFR3 mutation for bladder cancer
- BCR-ABL detection
- PML-RARA detection
- ALL translocation panel
- AML translocation panel
- HLA typing
- Paternity testing
Pre-implantation genetic screening (PGS)
Pre-implantation genetic screening (PGS)
Pre-implantation genetic screening (PGS, also called PGT-A) is a test designed for those undergoing IVF (in-vitro fertlization) procedures. PGS can identify the embryos that if implanted can lead to babies with syndromes like Down, Edward, Patau, Turner & Klinefelter.
Other benefits of this test are,
- Higher chances of pregnancy
- Reduced risk of miscarriages
- More confidence in transferring a single embryo, avoiding health risks associated with twin or triplet pregnancies
- Reduced number of IVF cycles needed to achieve pregnancy, potentially reducing the time to pregnancy and the costs of extra cycles